Body mass index and the association between low-density lipoprotein cholesterol as predicted by HMGCR genetic variants and breast cancer risk

Int J Epidemiol. 2019 Oct 1;48(5):1727-1730. doi: 10.1093/ije/dyz047.

Siddhartha P Kar¹, Hermann Brenner^{2

3

4}, Graham G Giles^{5

6}, Dezheng Huo⁷, Roger L Milne^{5

6}, Gad Rennert⁸, Jacques Simard⁹, Wei Zheng¹⁰, Stephen Burgess^{1

11}, Paul D P Pharoah^{1

12}

¹ Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
² Division of Clinical Epidemiology and Ageing Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
³ German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
⁴ Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
⁵ Cancer Epidemiology and Intelligence Division, Cancer Council Victoria, Melbourne, VIC, Australia.
⁶ Center for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Parkville, VIC, Australia.
⁷ Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.
⁸ Clalit National Cancer Control Center, at Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel.
⁹ Genomics Center, Centre Hospitalier Universitaire de Québec Université Laval Research Center, Québec City, QC, Canada.
¹⁰ Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
¹¹ MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.
¹² Department of Oncology, University of Cambridge, Cambridge, UK.

No abstract available

Publication types